Compare · MDLN vs SWAV
MDLN vs SWAV
Side-by-side comparison of Medline Inc. (MDLN) and Shockwave Medical Inc. (SWAV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SWAV operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 10.2x SWAV ($4.73B).
- MDLN has hit the wire 7 times in the past 4 weeks while SWAV has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 21 for SWAV).
- Company
- Medline Inc.
- Shockwave Medical Inc.
- Price
- $35.95-1.74%
- $334.80-0.01%
- Market cap
- $48.08B
- $4.73B
- 1M return
- +11.97%
- -
- 1Y return
- -11.77%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2019
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 21
Shockwave Medical Inc.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest SWAV
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
- Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Bruker Appoints Laura Francis to its Board of Directors
- Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
- SEC Form 15-12G filed by Shockwave Medical Inc.
- Francis Laura returned 4,784 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Moll Frederic H returned 287,521 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Papiernik Antoine returned 34,913 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Sainz Maria returned 5,328 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form S-8 POS filed by Shockwave Medical Inc.